Calderwood Stuart K, Neckers Len
Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Adv Cancer Res. 2016;129:89-106. doi: 10.1016/bs.acr.2015.08.002. Epub 2015 Oct 12.
Hsp90 plays a key role in fostering metabolic pathways essential in tumorigenesis through its functions as a molecular chaperone. Multiple oncogenic factors in the membrane and cytoplasm are thus protected from degradation and destruction. Here, we have considered Hsp90's role in transcription in the nucleus. Hsp90 functions both in regulating the activity of sequence-specific transcription factors such as nuclear receptors and HSF1, as well as impacting more globally acting factors that act on chromatin and RNA polymerase II. Hsp90 influences transcription by modulating histone modification mediated by its clients SMYD3 and trithorax/MLL, as well as by regulating the processivity of RNA polymerase II through negative elongation factor. It is not currently clear how the transcriptional role of Hsp90 may be influenced by the cancer milieu although recently discovered posttranslational modification of the chaperone may be involved. Dysregulation of Hsp90 may thus influence malignant processes both by modulating the function of specific transcription factors and effects on more globally acting general components of the transcriptional machinery.
热休克蛋白90(Hsp90)作为分子伴侣,在促进肿瘤发生所必需的代谢途径中发挥关键作用。因此,膜和细胞质中的多种致癌因子受到保护,免于降解和破坏。在此,我们探讨了Hsp90在细胞核转录中的作用。Hsp90不仅在调节序列特异性转录因子(如核受体和热休克因子1)的活性方面发挥作用,还会影响作用于染色质和RNA聚合酶II的更具全局性的因子。Hsp90通过调节其客户蛋白SMYD3和三体胸苷酸/混合谱系白血病(trithorax/MLL)介导的组蛋白修饰,以及通过负性延伸因子调节RNA聚合酶II的持续合成能力来影响转录。目前尚不清楚癌症环境如何影响Hsp90的转录作用,不过最近发现的该伴侣蛋白的翻译后修饰可能与此有关。因此,Hsp90的失调可能通过调节特定转录因子的功能以及影响转录机制中更具全局性的一般成分,进而影响恶性进程。